Paragon Sports Medicine

NAD+ IV Therapy in Atlanta

NAD+ is a coenzyme involved in cellular energy metabolism. At our Atlanta clinic, NAD+ IV therapy is delivered as a slow, medically supervised infusion built around your goals.

NAD+ levels naturally decline with age and are further depleted by chronic stress, illness, substance use, and metabolic issues. Low NAD+ levels are linked to age-related diseases, brain health problems, and metabolic dysfunction. IV administration delivers NAD+ directly into your bloodstream for rapid absorption and higher levels than oral supplements can achieve.

NAD+ is a dietary supplement ingredient. It is not FDA approved to treat any disease, and its use here is off label. Nothing on this page is medical advice.

Overview

NAD+ consists of two nucleotide moieties: one containing an adenine base and the other containing nicotinamide. These are linked through their phosphate groups, creating a molecule capable of accepting and donating electrons. NAD+ exists in oxidized (NAD+) and reduced (NADH) forms, with the NAD+/NADH ratio serving as a critical indicator of cellular redox state and metabolic health.

The molecule's structure allows it to function as a hydride acceptor, accepting two electrons and one proton to form NADH during catabolic reactions. This fundamental property enables NAD+ to drive cellular respiration and energy production in mitochondria while supporting hundreds of enzymatic reactions throughout the body.

Patient consulting with Dr. Ched Garten at Paragon, symbolizing advanced non-surgical care for joint, tendon, muscle, and pain issues.

Chemical structure & Properties

  • Molecular Formula: C₂₁H₂₇N₇O₁₄P₂
  • Molecular Weight: 663.43 g/mol
  • Chemical Name: β-Nicotinamide adenine dinucleotide
  • Chemical Class: Dinucleotide coenzyme
  • Structure: Composed of two nucleotides joined by phosphate groups
  • Stability: Stable in solution when properly prepared; light-sensitive

Mechanism of Action

Cellular Energy Metabolism and Mitochondrial Function

  • Serves as essential coenzyme in glycolysis, citric acid cycle, and oxidative phosphorylation
  • Acts as electron carrier in the mitochondrial electron transport chain
  • Enables ATP production by facilitating electron transfer from nutrients to oxygen
  • May support mitochondrial biogenesis and function
  • May support cellular energy availability and metabolic efficiency
  • Improves mitochondrial membrane potential and respiratory capacity

Sirtuin Activation

  • Serves as required substrate for sirtuin (SIRT1-7) enzymes
  • May activate SIRT1, which is involved in DNA repair, metabolic regulation, and stress resistance
  • May support mitochondrial sirtuins (SIRT3-5) and mitochondrial health
  • Regulates gene expression related to aging and cellular senescence
  • May influence circadian rhythm regulation through SIRT1
  • Involved in sirtuin signalling pathways studied in aging research

DNA Repair and Genomic Stability

  • Required substrate for poly(ADP-ribose) polymerases (PARPs) involved in DNA repair
  • May support base excision repair and single-strand break repair mechanisms
  • May help protect genomic integrity under oxidative stress
  • Maintains telomere function and chromosomal stability
  • May support cellular stress response and resilience
  • Involved in DNA repair processes

Neurological Function

  • May support neuronal energy metabolism and synaptic function
  • May support neurotransmitter synthesis, including serotonin and dopamine
  • May help protect neurons from oxidative stress
  • May support neuroplasticity and cognitive function
  • May help reduce neuroinflammation
  • May support myelin and neuronal connectivity
  • May protect against age-related cognitive decline

Metabolic Regulation

  • May influence glucose and lipid metabolism through sirtuin activity
  • May support insulin sensitivity and glucose balance
  • May support fatty acid oxidation and metabolic flexibility
  • Regulates circadian metabolic rhythms
  • May support a healthy inflammatory response
  • May improve body composition and metabolic parameters

LIVER METABOLISM AND CELLULAR REPAIR

  • May support the liver's normal metabolic pathways
  • May support antioxidant enzyme systems
  • May help reduce oxidative stress
  • May support autophagy and cellular cleanup
  • Facilitates removal of damaged cellular components

WHAT TO EXPECT

Response varies considerably between individuals and is not predictable in advance. NAD+ has not been shown in controlled clinical trials to produce a specific outcome on a specific timeline, so we do not promise one. What we do is set a plan, review how you respond, and adjust.

Infusions run slowly, typically two to four hours, and the rate is adjusted to your comfort throughout.

Protocol Considerations: Initial intensive protocols (daily infusions for 5-10 days) may provide rapid NAD+ restoration with more pronounced acute benefits. Monthly maintenance infusions help sustain elevated NAD+ levels and ongoing therapeutic effects. Individual responses vary based on baseline NAD+ status, age, health conditions, and lifestyle factors.

Safety Profile and Considerations

Clinical Safety

NAD+ IV therapy has a generally favorable reported safety profile with growing clinical experience. Most side effects are infusion-related and short-lived, and usually ease with a slower rate. Serious adverse events are rare when administered appropriately.

Potential Side Effects

Common (Infusion-Related):

  • Nausea or abdominal discomfort (most common, dose and rate-dependent)
  • Flushing or warmth sensation
  • Chest tightness or pressure (typically mild, resolves with slower infusion)
  • Headache during or after infusion
  • Muscle cramping or fasciculations
  • Lightheadedness or dizziness
  • Anxiety or restlessness during infusion
  • Fatigue immediately post-infusion (typically followed by energy increase)

Management: Most side effects are mitigated by slowing infusion rate. Many practitioners start with slower rates and gradually increase as tolerated. Symptoms typically resolve within minutes of rate reduction and disappear after infusion completion.

Uncommon:

  • Significant gastrointestinal upset
  • Persistent headache
  • Sleep disturbances (if administered late in day)
  • Temporary increase in anxiety

Rare:

  • Severe allergic reactions
  • Significant cardiovascular symptoms
  • Prolonged adverse effects

Precautions

  • Cardiovascular Conditions: Use with caution in patients with significant heart disease. Monitor vital signs during infusion. Chest tightness, though usually benign and infusion-rate related, should be evaluated carefully in cardiac patients.
  • Liver Disease: NAD+ metabolism occurs primarily in the liver. Patients with severe hepatic impairment should be evaluated individually and may require modified protocols.
  • Cancer Considerations: Theoretical concern exists regarding NAD+'s role in cellular proliferation and DNA repair, which could potentially support cancer cell metabolism. While no evidence suggests NAD+ promotes cancer, cautious use is recommended in patients with active malignancy. Consultation with the oncology team advised.
  • Pregnancy and Lactation: Avoid use during pregnancy and breastfeeding due to insufficient safety data. No studies have evaluated safety in these populations.
  • Methylation Concerns: High-dose NAD+ therapy may increase methylation demand. Consider co-administration with methylation support (methylated B vitamins, trimethylglycine) in some patients, particularly those with MTHFR variants.

Contraindications

  • Known hypersensitivity to NAD+ or components
  • Pregnancy and breastfeeding
  • Active malignancy without oncology consultation (relative contraindication)
  • Severe cardiovascular instability
  • Uncontrolled psychiatric conditions (relative contraindication)

Drug Interactions

  • Limited Known Interactions: NAD+ has relatively few direct drug interactions due to its endogenous nature. However, considerations include:
  • Chemotherapy: Timing of NAD+ therapy relative to chemotherapy should be discussed with oncology team, as NAD+ supports DNA repair mechanisms.
  • Benzodiazepines and Sedatives: NAD+ may reduce effectiveness or withdrawal symptoms in addiction recovery settings.
  • Stimulants: Additive effects on energy and alertness possible.

Monitoring Requirements

  • Vital signs monitoring during infusion (blood pressure, heart rate, respiratory rate)
  • Continuous assessment for infusion reactions
  • Adjustment of infusion rate based on tolerance
  • Post-infusion observation period
  • Assessment of therapeutic response over treatment course

Regulatory Status and

Clinical Use

FDA Status

Not FDA-approved as a therapeutic agent; classified as a dietary supplement ingredient

Off-Label Medical Use

Used by healthcare providers in clinical settings for a range of wellness goals

Compounding Status

Available through compounding pharmacies for IV formulation under medical supervision

Quality Considerations

Available through compounding pharmacies for IV formulation under medical supervision

IV NAD+ therapy represents an off-label application based on established biochemical importance, growing clinical experience, and emerging research evidence. Healthcare providers may recommend NAD+ therapy when potential benefits align with patient needs and standard treatments are insufficient.

Clinical Considerations

The Paragon Method: Step-by-Step

Administration and Treatment

  • Route: Intravenous infusion administered slowly over extended period
  • Infusion Rate: Typically 2-4 hours per session; rate adjusted based on tolerance (slower rates reduce side effects)
  • Initial Protocol: Common approach involves 5-10 consecutive daily infusions for acute restoration
  • Maintenance: Monthly or bi-monthly infusions to sustain elevated NAD+ levels
  • Timing: Morning or early afternoon administration preferred to avoid sleep interference
Woman in a gray hoodie sitting cross-legged on a gray armchair holding a water bottle and smiling gently.

Patient Selection

Appropriate candidates are determined at a clinical evaluation, including a full medication review.

Woman in a gray hoodie sitting cross-legged on a gray armchair holding a water bottle and smiling gently.

Pre-Treatment Assessment

  • Comprehensive medical and medication history
  • Baseline energy, cognitive, and functional assessment
  • Cardiovascular screening for significant heart disease
  • Discussion of realistic expectations and protocol commitment
  • Evaluation of methylation status and supplementation needs
  • Informed consent regarding off-label use
Woman in a gray hoodie sitting cross-legged on a gray armchair holding a water bottle and smiling gently.

Optimization Strategies

  • Adequate hydration before infusion
  • Light meal 1-2 hours prior (not on empty stomach)
  • Comfortable setting with ability to recline
  • Entertainment or relaxation activities during lengthy infusion
  • Methylation support supplementation (B vitamins) when appropriate
  • Lifestyle modifications supporting NAD+ levels (exercise, sleep, stress management, dietary optimization)
  • Avoidance of NAD+-depleting substances (excessive alcohol, smoking)
Woman in a gray hoodie sitting cross-legged on a gray armchair holding a water bottle and smiling gently.

During Infusion Management

  • Start with slower infusion rates and increase as tolerated
  • Immediate rate reduction if discomfort develops
  • Patient communication and comfort monitoring
  • Availability of anti-nausea medication if needed
  • Vital sign monitoring at regular intervals
Woman in a gray hoodie sitting cross-legged on a gray armchair holding a water bottle and smiling gently.

Post-Treatment Care

  • Brief observation period after infusion completion
  • Hydration encouragement
  • Rest if fatigue present (typically brief)
  • Assessment of immediate response and side effects
  • Scheduling of subsequent treatments in protocol
  • Ongoing evaluation of cumulative therapeutic benefits
Woman in a gray hoodie sitting cross-legged on a gray armchair holding a water bottle and smiling gently.

Monitoring

  • Session-by-session tolerance and side effect assessment
  • Progressive evaluation of energy, cognitive function, and primary treatment goals
  • Adjustment of infusion rate or protocol based on response
  • Long-term monitoring of sustained benefits with maintenance protocols
Woman in a gray hoodie sitting cross-legged on a gray armchair holding a water bottle and smiling gently.
Man seated indoors with a soccer ball in natural light, representing Paragon’s musculoskeletal recovery expertise and regenerative treatment focus.

Conclusion

NAD+ is a coenzyme involved in cellular energy metabolism, and levels decline with age. IV administration raises blood levels.

The biochemistry is well characterized. Whether raising NAD+ produces clinical benefit in any specific condition is a separate question, and one the evidence has not yet answered.

Infusion-related side effects are common but usually manageable through rate adjustment and resolve quickly. Experienced practitioners and appropriate monitoring support safe sessions. Longer infusion times and multiple sessions call for some time commitment.

References

Verdin E. NAD⁺ in aging, metabolism, and neurodegeneration. Science. 2015;350(6265):1208-1213.

Braidy N, et al. NAD+ therapy in age-related degenerative disorders: A benefit/risk analysis. Exp Gerontol. 2020;132:110831.

Rajman L, et al. Therapeutic potential of NAD-boosting molecules: The in vivo evidence. Cell Metab. 2018;27(3):529-547.

Yoshino J, et al. NAD+ intermediates: The biology and therapeutic potential of NMN and NR. Cell Metab. 2018;27(3):513-528.

Cantó C, et al. NAD+ metabolism and the control of energy homeostasis: A balancing act between mitochondria and the nucleus. Cell Metab. 2015;22(1):31-53.

Imai S, Guarente L. NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014;24(8):464-471.

Disclaimer: This information is provided for educational purposes only and does not constitute medical advice. NAD+ IV therapy is not FDA-approved for the treatment of any disease and represents off-label use of a dietary supplement ingredient. Patients should consult with qualified healthcare providers before considering any IV therapy. The content reflects current scientific literature and clinical practice as of 2025. Individual results may vary, and treatment appropriateness should be determined on a case-by-case basis by licensed medical professionals. NAD+ IV therapy requires extended infusion times and multiple sessions for optimal results, necessitating significant time commitment and proper medical supervision.

Frequently Asked Questions

About NAD+ IV therapy

What is NAD+ IV therapy?
What does the evidence show for NAD+ IV therapy?
How long does a NAD+ IV session take?
Is NAD+ IV therapy safe?
How often should I get NAD+ IV therapy?
Where can I get NAD+ IV therapy in Atlanta?
What is NAD+ IV therapy?
What does the evidence show for NAD+ IV therapy?
How long does a NAD+ IV session take?
Is NAD+ IV therapy safe?
How often should I get NAD+ IV therapy?
Where can I get NAD+ IV therapy in Atlanta?